Initial Treatment of Patients With Immune Thrombocytopenic Purpura
Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This study will compare treatment with 3 courses of high-dose dexamethasone versus treatment
with prednisone, for patients recently diagnosed with immune thrombocytopenic purpura (ITP).
The primary hypothesis is that patients treated with high-dose dexamethasone will obtain a
more durable remission than patients treated with prednisone.